Table II.
Variable | % (No.) (N = 192) |
---|---|
| |
Procedure status | |
Elective | 75.0 (144) |
Urgent or emergent | 25.0 (48) |
Indication for TEVAR | |
DTA, fusiform | 55.2 (106) |
DTA, saccular | 41.7 (80) |
DTA, fusiform and saccular | 3.1 (6) |
Access vessel | |
Femoral | 82.8 (159) |
Iliac | 17.2 (33) |
Infrarenal aorta | 0.5 (1) |
Other | 1.0 (2) |
Left subclavian artery coverage | 45.8 (88) |
Maximum aortic diameter, cm | 5.9 ± 1.5 |
Type of endograft | |
Gore TAG/C-TAGa | 57.8 (111) |
Medtronic Talent/Valiantb | 24.0 (46) |
Cook Zenith TX2/Alpha Thoracicc | 16.1 (31) |
Bolton Relayd | 1.6 (3) |
Medtronic Aneurxb | 0.5 (1) |
Endografts used, median | 2 (1–5) |
Intraoperative CSF drainage | 12.5 (24) |
CSF, Cerebrospinal fluid; DTA, descending thoracic aneurysm; TEVAR, thoracic endovascular aortic repair.
W. L. Gore and Associates, Flagstaff, Ariz.
Medtronic, Minneapolis, Minn.
Cook, Bloomington, Ind.
Bolton Medical, Inc, Sunrise, Fla.